Hull early walking aid for rehabilitation of trans-tibial amputees-randomised controlled trial (HEART)
(2010)
Presentation / Conference Contribution
Hancock, A., Mazari, F., Chetter, I., & Vanicek, N. Hull early walking aid for rehabilitation of trans-tibial amputees-randomised controlled trial (HEART)
All Outputs (5)
Generic quality of life: selecting the optimal patient reported outcome measure in venous intervention (2010)
Presentation / Conference Contribution
Mekako, A., Carradice, D., Samuel, N., Bradley, S., & Chetter, I. Generic quality of life: selecting the optimal patient reported outcome measure in venous intervention
Patients' experiences and satisfaction following elective abdominal aortic aneurysm (AAA) repair (2010)
Presentation / Conference Contribution
Mazari, F., Abdul Rahman, H., Khan, J., Mockford, K., McCollum, P., & Chetter, I. Patients' experiences and satisfaction following elective abdominal aortic aneurysm (AAA) repair
Prospective observational study for comparison of use of Short Form-36 dimension scores and patient responses for derivation of preference based Short Form-6D index to calculate of quality adjusted life years (QALYs) for economic analyses in patients with (2010)
Presentation / Conference Contribution
Mazari, F., Abdul Rahman, H., Khan, J., Mockford, K., McCollum, P., & Chetter, I. Prospective observational study for comparison of use of Short Form-36 dimension scores and patient responses for derivation of preference based Short Form-6D index to calculate of quality adjusted life years (QALYs) for economic analyses in patients with
Cost utility analysis of a randomised control trial of percutaneous transluminal angioplasty (PTA), supervised exercise programme (SEP) and combined treatment (PTA plus SEP) for patients with intermittent claudication (IC) due to femoropopliteal disease (2010)
Presentation / Conference Contribution
Mazari, F., Abdul Rahman, H., Khan, J., McCollum, P., Gulati, S., Mehta, T., & Chetter, I. Cost utility analysis of a randomised control trial of percutaneous transluminal angioplasty (PTA), supervised exercise programme (SEP) and combined treatment (PTA plus SEP) for patients with intermittent claudication (IC) due to femoropopliteal disease